ACADIAN ASSET MANAGEMENT LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 69 filers reported holding PROQR THRAPEUTICS N V in Q3 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q4 2022$63
-100.0%
17,256
-90.8%
0.00%
-100.0%
Q3 2022$138,000
+1625.0%
187,034
+1995.6%
0.00%
Q1 2022$8,000
-68.0%
8,925
+144.9%
0.00%
Q2 2021$25,0003,645
+3545.0%
0.00%
Q4 2017$01000.0%0.00%
Q3 2017$0
-100.0%
100
-98.4%
0.00%
Q4 2016$31,000
-89.8%
6,422
-64.6%
0.00%
-100.0%
Q2 2015$303,00018,1520.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders